Key result
Trimetazidine pretreatment reduces myocardial infarct size by an absolute ~22 percentage points in acute ischemia.
Why the study?
Does oral trimetazidine pretreatment reduce myocardial infarct size and preserve mitochondrial respiratory function, biosynthesis, and fission/fusion in rats with acute myocardial ischemia?
Does oral trimetazidine pretreatment reduce myocardial infarct size and preserve mitochondrial respiratory function, biosynthesis, and fission/fusion in rats with acute myocardial ischemia?
In a rat model of acute myocardial ischemia, 7-day pretreatment with trimetazidine reduced infarct size and preserved mitochondrial structure, respiration, biogenesis (PGC-1α), and fission/fusion dynamics (Drp1, Mfn1, Opa1).
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for trimetazidine in ischemia; human trials needed before clinical consideration.
OBJECTIVE: Myocardial ischemia affects mitochondrial functions, leading to ionic imbalance and susceptibility to ventricular fibrillation. Trimetazidine, a metabolic agent, is clinically used in anti-anginal therapy. METHODS: In this study, the rats were orally treated by gavage with trimetazidine 10 mg/kg/d for 7 days, and the effects of trimetazidine on mitochondrial respiratory function, biosynthesis, and fission/fusion in rats with acute myocardial ischemia were evaluated. RESULTS: It has been suggested that acute myocardial ischemia leads to a damage to mitochondrial functions. However, compared with ischemia group without trimetazidine administration, a significant reduction in the infarct size was observed in trimetazidine-treated ischemia group (31.24±3.02% vs. 52.87±4.89%). Trimetazidine preserved the mitochondrial structure and improved respiratory control ratio and complex I activity. Furthermore, trimetazidine improved mitochondrial biosynthesis and fission/fusion, as demonstrated by the promotion of peroxisome proliferator-activated receptor gamma (PPARγ) co-activator 1α (PGC-1α), mitofusins 1 (Mfn1), dynamin-related protein 1 (Drp1), and optic atrophy 1 (Opa1) expressions in rats with acute myocardial ischemia. CONCLUSION: Taken together, it was suggested that in this rat model of myocardial ischemia, trimetazidine demonstrated cardioprotective effects attributing to the preservation of mitochondrial respiratory function, biosynthesis, and fission/fusion and, thus, could be considered as an agent for cardioprotection.
No takes yet. Share an insight, caveat, or question.
Wen Shi (2017) studied Acute myocardial ischemia in adult male Wistar rats (n=80). Trimetazidine vs. Saline solution [0.9% NaCl (w/v)] orally by gavage was evaluated on Myocardial infarct size percentage (p=<0.05). Trimetazidine pretreatment reduced myocardial infarct size and preserved mitochondrial function in rats with acute myocardial ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: